IFP Advisors’s Eikon Therapeutics EIKN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.79K Buy
969
+51
+6% +$513 ﹤0.01% 3554
2026
Q2
$12K Buy
+918
New +$9.37K ﹤0.01% 3275

Other funds holding EIKN

IFP Advisors's EIKN Position: Q3 2026 in Review

IFP Advisors increased its Eikon Therapeutics (EIKN) stake by 5.6% in Q3 2026, buying an estimated $513 and bringing the position to 969 shares worth $7.79K. The position accounts for ﹤0.01% of the portfolio, ranked #3554.

IFP Advisors first reported a position in EIKN in Q2 2026 and has held it in 2 quarters since. The position peaked at $12K in Q2 2026. 95 funds tracked by Wall St. Rank hold EIKN as of Q3 2026.

  • IFP Advisors held 969 shares of Eikon Therapeutics worth $7.79K as of Q3 2026.
  • IFP Advisors bought 51 Eikon Therapeutics shares in Q3 2026, an estimated $513.
  • Eikon Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #3554 holding.
  • IFP Advisors first reported a position in Eikon Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • IFP Advisors's Eikon Therapeutics position peaked at $12K in Q2 2026.
  • 95 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.